Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select strict versus relaxed maternal glycemic targets.
Kjos
Siri L
SL
Department of Obstetrics and Gynecology, University of California, Los Angeles, California, USA. skjos@obgyn.humc.edu
Schaefer-Graf
Ute M
UM
D000005:Abdomen / Q000033:anatomy & histology; D001786:Blood Glucose / Q000378:metabolism*; D016640:Diabetes, Gestational / Q000188:drug therapy*; D005260:Female; D047109:Fetal Development; D005320:Fetal Macrosomia / Q000517:prevention & control; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic; D012016:Reference Values; D016216:Ultrasonography, Prenatal
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin